Ablative Fractional Laser-assisted Low-irradiance Photodynamic Therapy for Treatment of Actinic Keratoses in Organ Transplant Recipients: A Prospective, Randomized, Intraindividual Controlled Trial
DOI:
https://doi.org/10.2340/actadv.v102.1057Keywords:
actinic keratosis, keratinocyte cancer, organ transplant recipients, photodynamic therapy, immunosuppressionAbstract
Pain and inferior efficacy are major limiting factors of conventional photodynamic therapy for the field treatment of actinic keratoses in immunosuppressed organ transplant recipients. This prospective randomized controlled study evaluates the efficacy and tolerability of ablative fractional laser system pretreatment combined with low-irradiance photodynamic therapy (18.5 mW/cm2) compared with conventional photodynamic therapy (61.67 mW/cm2) in the treatment of actinic keratoses on the face and scalp in organ transplant recipients, using a red light-emitting diode lamp at a total light dose of 37 J/cm2. Low-irradiance photodynamic therapy combined with Er:YAG pretreatment achieved a significantly superior lesion response rate (mean ± standard deviation 77.3 ± 23.6%) compared with conventional photodynamic therapy (61.8 ± 21.4%; p = 0.025) in intra-individual fields at 3 months without negatively impacting pain (p = 0.777) or cosmetic outcome (p = 0.157).
Downloads
References
Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-1691.
https://doi.org/10.1056/NEJMra022137 DOI: https://doi.org/10.1056/NEJMra022137
Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17; quiz 18-20.
https://doi.org/10.1067/mjd.2002.125579 DOI: https://doi.org/10.1067/mjd.2002.125579
O'Reilly Zwald F, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 253-261.
https://doi.org/10.1016/j.jaad.2010.11.062 DOI: https://doi.org/10.1016/j.jaad.2010.11.062
Basset-Seguin N, Baumann Conzett K, Gerritsen MJ, Gonzalez H, Haedersdal M, Hofbauer GF, et al. Photodynamic therapy for actinic keratosis in organ transplant patients. J Eur Acad Dermatol Venereol 2013; 27: 57-66.
https://doi.org/10.1111/j.1468-3083.2011.04356.x DOI: https://doi.org/10.1111/j.1468-3083.2011.04356.x
Czarnecki D, Meehan CJ, Bruce F, Culjak G. The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J Cutan Med Surg 2002; 6: 207-209.
https://doi.org/10.1177/120347540200600301 DOI: https://doi.org/10.1177/120347540200600301
Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 1: 795-797.
https://doi.org/10.1016/S0140-6736(88)91658-3 DOI: https://doi.org/10.1016/S0140-6736(88)91658-3
Mittelbronn MA, Mullins DL, Ramos-Caro FA, Flowers FP. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol 1998; 37: 677-681.
https://doi.org/10.1046/j.1365-4362.1998.00467.x DOI: https://doi.org/10.1046/j.1365-4362.1998.00467.x
Euvrard S, Kanitakis J, Pouteil-Noble C, Dureau G, Touraine JL, Faure M, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222-229.
https://doi.org/10.1016/0190-9622(95)90239-2 DOI: https://doi.org/10.1016/0190-9622(95)90239-2
Hartmann J, Schuler S, Enk AH, Lonsdorf AS. Skin cancer in organ transplant recipients: dynamics in the incidence and clinical predictors for the first and subsequent post-transplant non-melanoma skin cancer. J Eur Acad Dermatol Venereol 2019; 33: 1281-1289.
https://doi.org/10.1111/jdv.15538 DOI: https://doi.org/10.1111/jdv.15538
Stratigos AJ, Garbe C, Dessinioti C, Lebbe C, Bataille V, Bastholt L, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention. Eur J Cancer 2020; 128: 60-82.
https://doi.org/10.1016/j.ejca.2020.01.007 DOI: https://doi.org/10.1016/j.ejca.2020.01.007
Cohen JL. Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer. J Clin Aesthet Dermatol 2010; 3: 39-44.
Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: 23-24.
https://doi.org/10.1067/mjd.2000.103339 DOI: https://doi.org/10.1067/mjd.2000.103339
O'Reilly Zwald F, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 263-279.
https://doi.org/10.1016/j.jaad.2010.11.063 DOI: https://doi.org/10.1016/j.jaad.2010.11.063
Wlodek C, Ali FR, Lear JT. Use of photodynamic therapy for treatment of actinic keratoses in organ transplant recipients. Biomed Res Int 2013; 2013: 349526.
https://doi.org/10.1155/2013/349526 DOI: https://doi.org/10.1155/2013/349526
Markham T, Collins P. Topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol 2001; 145: 502-504.
https://doi.org/10.1046/j.1365-2133.2001.04385.x DOI: https://doi.org/10.1046/j.1365-2133.2001.04385.x
Dragieva G, Prinz BM, Hafner J, Dummer R, Burg G, Binswanger U, et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004; 151: 196-200.
https://doi.org/10.1111/j.1365-2133.2004.06054.x DOI: https://doi.org/10.1111/j.1365-2133.2004.06054.x
Dragieva G, Scharer L, Dummer R, Kempf W. Photodynamic therapy - a new treatment option for epithelial malignancies of the skin. Onkologie 2004; 27: 407-411.
https://doi.org/10.1159/000079098 DOI: https://doi.org/10.1159/000079098
Liew YCC, De Souza NNA, Sultana RG, Oh CC. Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2020; 34: 251-259.
https://doi.org/10.1111/jdv.15852 DOI: https://doi.org/10.1111/jdv.15852
Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br J Cancer 1996; 74: 22-29.
https://doi.org/10.1038/bjc.1996.310 DOI: https://doi.org/10.1038/bjc.1996.310
Dragieva G, Hafner J, Dummer R, Schmid-Grendelmeier P, Roos M, Prinz BM, et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004; 77: 115-121.
https://doi.org/10.1097/01.TP.0000107284.04969.5C DOI: https://doi.org/10.1097/01.TP.0000107284.04969.5C
Ko DY, Jeon SY, Kim KH, Song KH. Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study. J Eur Acad Dermatol Venereol 2014; 28: 1529-1539.
https://doi.org/10.1111/jdv.12334 DOI: https://doi.org/10.1111/jdv.12334
Togsverd-Bo K, Haak CS, Thaysen-Petersen D, Wulf HC, Anderson RR, Haedersdal M. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol 2012; 166: 1262-1269.
https://doi.org/10.1111/j.1365-2133.2012.10893.x DOI: https://doi.org/10.1111/j.1365-2133.2012.10893.x
Tyrrell JS, Campbell SM, Curnow A. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome. Lasers Surg Med 2010; 42: 613-619.
https://doi.org/10.1002/lsm.20943 DOI: https://doi.org/10.1002/lsm.20943
Haedersdal M, Sakamoto FH, Farinelli WA, Doukas AG, Tam J, Anderson RR. Fractional CO(2) laser-assisted drug delivery. Lasers Surg Med 2010; 42: 113-122.
https://doi.org/10.1002/lsm.20860 DOI: https://doi.org/10.1002/lsm.20860
Haedersdal M, Katsnelson J, Sakamoto FH, Farinelli WA, Doukas AG, Tam J, et al. Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment. Lasers Surg Med 2011; 43: 804-813.
https://doi.org/10.1002/lsm.21096 DOI: https://doi.org/10.1002/lsm.21096
Forster B, Klein A, Szeimies RM, Maisch T. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation. Exp Dermatol 2010; 19: 806-812.
https://doi.org/10.1111/j.1600-0625.2010.01093.x DOI: https://doi.org/10.1111/j.1600-0625.2010.01093.x
Choi SH, Kim KH, Song KH. Effect of methyl aminolevulinate photodynamic therapy with and without ablative fractional laser treatment in patients with microinvasive squamous cell carcinoma: a randomized clinical trial. JAMA Dermatol 2017; 153: 289-295.
https://doi.org/10.1001/jamadermatol.2016.4463 DOI: https://doi.org/10.1001/jamadermatol.2016.4463
Gholam P, Bosselmann I, Enk AH, Dick J. Low irradiance compared with conventional photodynamic therapy in the treatment of actinic keratoses. Photodermatol Photoimmunol Photomed 2019; 35: 110-115.
https://doi.org/10.1111/phpp.12431 DOI: https://doi.org/10.1111/phpp.12431
Olsen EA, Abernethy ML, Kulp-Shorten C, Callen JP, Glazer SD, Huntley A, et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24: 738-743.
https://doi.org/10.1016/0190-9622(91)70113-G DOI: https://doi.org/10.1016/0190-9622(91)70113-G
Dirschka T, Pellacani G, Micali G, Malvehy J, Stratigos AJ, Casari A, et al. A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index. J Eur Acad Dermatol Venereol 2017; 31: 1295-1302.
https://doi.org/10.1111/jdv.14267 DOI: https://doi.org/10.1111/jdv.14267
Fink C, Enk A, Gholam P. Photodynamic therapy - aspects of pain management. J Dtsch Dermatol Ges 2015; 13: 15-22.
https://doi.org/10.1111/ddg.12546 DOI: https://doi.org/10.1111/ddg.12546
Borgia F, Giuffrida R, Caradonna E, Vaccaro M, Guarneri F, Cannavo SP. Early and late onset side effects of photodynamic therapy. Biomedicines 2018; 6: 12.
https://doi.org/10.3390/biomedicines6010012 DOI: https://doi.org/10.3390/biomedicines6010012
Togsverd-Bo K, Lei U, Erlendsson AM, Taudorf EH, Philipsen PA, Wulf HC, et al. Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial. Br J Dermatol 2015; 172: 467-474.
https://doi.org/10.1111/bjd.13222 DOI: https://doi.org/10.1111/bjd.13222
Steinbauer JM, Schreml S, Babilas P, Zeman F, Karrer S, Landthaler M, et al. Topical photodynamic therapy with porphyrin precursors - assessment of treatment-associated pain in a retrospective study. Photochem Photobiol Sci 2009; 8: 1111-1116.
https://doi.org/10.1039/b823378k DOI: https://doi.org/10.1039/b823378k
Fink C, Uhlmann L, Enk A, Gholam P. Pain management in photodynamic therapy using a nitrous oxide/oxygen mixture: a prospective, within-patient, controlled clinical trial. J Eur Acad Dermatol Venereol 2017; 31: 70-74.
https://doi.org/10.1111/jdv.13788 DOI: https://doi.org/10.1111/jdv.13788
Schmitz L, von Dobbeler C, Gupta G, Gambichler T, Szeimies RM, Morton CA, et al. Photodynamic therapy leads to significant improvement of actinic keratosis area and severity index (AKASI). Photodiagnosis Photodyn Ther 2018; 21: 66-70.
https://doi.org/10.1016/j.pdpdt.2017.10.007 DOI: https://doi.org/10.1016/j.pdpdt.2017.10.007
Morton CA, Wulf HC, Szeimies RM, Gilaberte Y, Basset-Seguin N, Sotiriou E, et al. Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus. J Eur Acad Dermatol Venereol 2015; 29: 1718-1723.
https://doi.org/10.1111/jdv.12974 DOI: https://doi.org/10.1111/jdv.12974
Gholam P, Bosselmann I, Enk A, Fink C. Impact of red versus blue light on tolerability and efficacy of PDT: a randomized controlled trial. J Dtsch Dermatol Ges 2018; 16: 711-717.
https://doi.org/10.1111/ddg.13545 DOI: https://doi.org/10.1111/ddg.13545
Grapengiesser S, Ericson M, Gudmundsson F, Larko O, Rosen A, Wennberg AM. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002; 27: 493-497.
https://doi.org/10.1046/j.1365-2230.2002.01065.x DOI: https://doi.org/10.1046/j.1365-2230.2002.01065.x
Arits AH, van de Weert MM, Nelemans PJ, Kelleners-Smeets NW. Pain during topical photodynamic therapy: uncomfortable and unpredictable. J Eur Acad Dermatol Venereol 2010; 24: 1452-1457.
https://doi.org/10.1111/j.1468-3083.2010.03670.x DOI: https://doi.org/10.1111/j.1468-3083.2010.03670.x
Published
How to Cite
License
Copyright (c) 2022 Anke S. Lonsdorf, Aric Keller, Julia Hartmann, Alexander H. Enk, Patrick Gholam
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
